Jump to content
RemedySpot.com

yaba daba doo

Rate this topic


Guest guest

Recommended Posts

Guest guest

On Tue, 31 May 2005 21:26:03 -0600 " Caermail " <caerfree@...>

writes:

> If it were me, I would never take the medications. I would rather

> die honestly. Besides, what it does to your T-Cells is merely a

> mask. You will feel better, all the while, killing your own bone

> marrow to the point that you are not able to produce any more.

)======== And what might those particular meds be that do this(I've only

heard of AZT doing that)? OH,.....so low cd'4s or what ever count you

have has absolutely no correlative or indication of anything going on in

your body relative to immunity - is that the claim? Dissidents have yet

to prove that cd-4's are irrelevant and the general data points

consisently to OI's being more 'opportunist' at lower cd-4 counts. While

these lower counts may or may not have anything to do with the hiv...they

still are usually a fairly good indicator on ones immune-response status.

(ave. cd-4's range from 500 - 1500) This is the general concensus...and

until it is disproven...it remains to be reckoned with.

A good cleanse sounds good!

paul

Link to comment
Share on other sites

Guest guest

I agree with you that survival has to be the top

priority at all cost. If it comes down to dying or

taking the meds, I would choose the meds.

Then, while you are surviving, you can make money and

go on a good alternative therapy to eventually go off

the meds for good.

Sylvain

--- J Purcell <freelightexpress@...> wrote:

>

> On Tue, 31 May 2005 21:26:03 -0600 " Caermail "

> <caerfree@...>

> writes:

>

> > If it were me, I would never take the medications.

> I would rather

> > die honestly. Besides, what it does to your

> T-Cells is merely a

> > mask. You will feel better, all the while,

> killing your own bone

> > marrow to the point that you are not able to

> produce any more.

>

>

> )======== And what might those particular meds be

> that do this(I've only

> heard of AZT doing that)? OH,.....so low cd'4s or

> what ever count you

> have has absolutely no correlative or indication of

> anything going on in

> your body relative to immunity - is that the claim?

> Dissidents have yet

> to prove that cd-4's are irrelevant and the general

> data points

> consisently to OI's being more 'opportunist' at

> lower cd-4 counts. While

> these lower counts may or may not have anything to

> do with the hiv...they

> still are usually a fairly good indicator on ones

> immune-response status.

> (ave. cd-4's range from 500 - 1500) This is the

> general concensus...and

> until it is disproven...it remains to be reckoned

> with.

>

> A good cleanse sounds good!

>

>

> paul

>

>

>

>

>

>

>

Musically yours,

Sylvain Gagnon

www.sylvaingagnon.net

info@...

__________________________________

Discover

Have fun online with music videos, cool games, IM and more. Check it out!

http://discover./online.html

Link to comment
Share on other sites

Guest guest

PAUL: " OH,.....so low cd'4s or what ever count you have has absolutely

no correlative or indication of anything going on in

your body relative to immunity - is that the claim? Dissidents have

yet to prove that cd-4's are irrelevant and the general data points

consisently to OI's being more 'opportunist' at lower cd-4 counts.

While these lower counts may or may not have anything to do with the

hiv...they still are usually a fairly good indicator on ones immune-

response status. "

Yes, , you know that's the claim... or more correctly, the

critique. What's the difference: claim or critique? I'll tell you and

others because many never have been able to understand this concept.

It's what a theory is and is not. A theory proposes some phenomenon

PROACTIVELY OR AFFIRMATIVELY DOES EXIST OR DOES CAUSE SOME REACTION

OR EFFECT. It is not a theory to contend that another theory is

flawed or failed and here is why. It is a critique or challenge to

bring that theory's validity under scrutiny and ultimate disrepute.

However, it is never the burden of proof of those critiquing or

challenging a theory to prove RETROACTIVELY OR DISAFFIRMATIVELY that

some phenomenon *DOES NOT* EXIST OR *DOES NOT* CAUSE SOME REACTION OR

EFFECT. You can't prove a negative and you shouldn't have to prove

innocense. This is assumed until proven guilty, that T-Cells are an

accurate or valid surrogate marker for health and wellness. First of

all, if they were, why wouldn't they be used in many other

applications. You don't hear of hardly any other group of sick people

having their T-Cells counted, do you? Doesn't that seem odd to you?

It should. Again, I recently asked you to provide the data from any

study that supported the conclusion that T-Cells are correlated to

illness or wellness with matched controls of socalled 'HIV' negative

versus socalled 'HIV' positive persons. You have not provided that

reference; neither have you indicated you have even sought that

reference out by inquiring of your socalled " HIV Specialists. " Then,

instead of requiring proof that T-Cells are accurate or valid markers

or measures of health and wellness, you ask AIDS Dissidents to prove

that they aren't accurate measures or markers of health and wellness.

It's kind of like saying, prove that you didn't steal that candy.

Rather difficult to do and rather unecessary if the proponants and

prosecutors of said theory have not proven their case, affirming that

T-Cells are accurate and valid measures or markers.

CD4/CD8 Cell Counts

Low CD4 cell counts (or abnormal CD4/CD8 ratios) are considered to be

an unambiguous sign of the progression of AIDS, yet science does not

support this. There are people with AIDS with normal CD4 cell counts

and healthy people with low CD4 cell counts. Over a large group of

people, it may well be true that on average, low CD4 cell counts

identify a group of people who are more likely to be in ill health,

but this logic does not apply to all individuals. Furthermore, even

if low CD4 cell counts were always associated with ill health, it

would not necessarily follow that artificially raising these counts

with toxic drugs would be beneficial.

CD4 cell counts are a type of Surrogate Marker, a lab measurement

that substitutes for a real measure of health. Consequently,

decisions made on the basis of CD4 cell counts should be interpreted

with caution, particularly decisions that could prove damaging, such

as starting antiretroviral medications.

" This population-based cohort of unselected adults in Misisi, a

shanty compound in Lusaka, has been under follow-up since 1999, and

CD4 cell counts have been followed in participants since the initial

survey. No antiretroviral drugs were used by any of the participants

over the period of the study…In the survivors, the mean decline over

4 years was 29 cells/micro-liter per year…Our data indicate that the

decline in CD4 cell counts over the period from 1999 to 2003 in

adults not treated with highly active antiretroviral therapy was

slow, and our estimate of the rate of loss of CD4 cells is in very

close agreement with the estimate of 21.5 cells/micro-liter per year

from Tanzania. These data support the idea that HIV progression to

AIDS and death is slower than at first thought, even in very under-

resourced populations living in crowded conditions. "

Katubulushi M et al. Slow decline in CD4 cell count in a cohort of

HIV-infected adults living in Lusaka, Zambia. AIDS. 2005 Jan 3;19

(1):102-3.

" a total of 614 healthy native Chinese adults who met inclusion

criteria were studied. Of these, mean age was 33.4 years (range, 16

to 50 years), and 377 (61.4%) were male…CD8 lymphocyte counts, which

averaged 539.6cells/microliter, were significantly higher in men than

in women, resulting in a significantly lower CD4/CD8 ratio in men. We

observed a mean CD4 level of 727 cells/ l for the healthy, HIV

antibody-negative Chinese adult residents of Shanghai, with no

significant differences according to age or gender. [Table 1 shows

that the range of CD4 cell counts was 252-2082, CD8 counts were from

193 to 1071 and the CD4/CD8 ratio varied from 0.47 to 4.62. Note that

a CD4 cell count less thann 200 or a CD4/CD8 ratio less than 0.14,

along with a positive HIV test and no illness, constitutes 'AIDS' in

the US] "

Jiang W, Kang L, Lu HZ et al. Normal values for CD4 and CD8

lymphocyte subsets in healthy Chinese adults from Shanghai. Clin

Diagn Lab Immunol. 2004 Jul;11(4):811-3.

" [Dr. ] Gazzard [retiring chair of the British HIV association]

had his own Aids scare. " I pricked myself on a needle. One of the

other doctors said: `Well, now you'll know what its like to be HIV

positive'. I spent three agonising months waiting till I could take

the test, and two sleepless nights waiting for the results. I did it

anonymously at another hospital. " It was negative, but in the process

they discovered I happened to have an unusually low CD4 count - 350 -

which has stayed that way ever since. " [Dr. Gazzard is healthy.] "

Cairns G. Interview with the professor. Positive Nation. 2004 Mar;100

http://www.positivenation.co.uk/issue100/features/feature6/feature6.ht

m.

" Baseline CD4 count was the strongest predictor of subsequent

clinical progression "

Mayer KH et al. Clinical and immunologic progression in HIV-infected

US women before and after the introduction of highly active

antiretroviral therapy. J Acquir Immune Defic Syndr. 2003 Aug 15;33

(5):614-24.

" After the addition of lipid-lowering agents, absolute CD4 T-cell

responses were lower in the statin group than in [the other three]

groups [of HIV-positive people taking antiretroviral therapy], when

measured after 6, 12, and 18 months of treatment. "

Narayan S et al. Attenuated T-Lymphocyte Response to HIV Therapy in

Individuals Receiving HMG-CoA Reductase Inhibitors. HIV Clin Trials.

2003 May-Jun;4(3):164-9

..

" A total of 1078 human immunodeficiency virus (HIV) type 1-infected

women from Tanzania were randomized in a placebo-controlled trial

using a factorial design to examine the effects of supplementation

with vitamin A (preformed vitamin A and beta carotene) and/or

multivitamins (vitamins B, C, and E). Supplements were given during

pregnancy and lactation [breastfeeding]. Children of women in the

multivitamin arms had a significantly lower risk of diarrhea than did

those in the no-multivitamin arm. The mean CD4+ cell count was 151

cells/microL higher among children in the multivitamin arms than

among those in the no-multivitamin arm [although not with Vitamin A,

indicating that CD4 cell counts can be increased in ways other than

giving anti-HIV drugs] "

Fawzi WW et al. Effect of providing vitamin supplements to human

immunodeficiency virus-infected, lactating mothers on the child's

morbidity and CD4+ cell counts. Clin Infect Dis. 2003 Apr 15;36

(8):1053-62.

" Among patients with <50 million cells/l the adjusted relative hazard

of mortality was 5.07 for patients of experienced physicians and was

11.99 among patients with inexperienced physicians, in comparison to

patients with >200 million cells/l treated by experienced physicians.

Similarly, among patients with >50 million cells/l, the adjusted

relative hazard of mortality was 6.19 for adherent patients and was

35.71 for non-adherent patients, in comparison to adherent patients

with > 200 million cells/l. "

Wood E, Hogg RS, Yip B et al. Is there a baseline CD4 cell count that

precludes a survival response to modern antiretroviral therapy?.

AIDS. 2003 Mar 28;17(5):711-720.

" Overall, neither the number nor the differentiation phenotype,

including perforin levels, of HIV-1-specific CD8+ T cells appear to

be correlated directly with the non-progressor state [CD8 cell counts

are often taken in conjunction with CD4 cell counts as representative

of the state of the immune system] "

Papagno L et al. Comparison between HIV- and CMV-specific T cell

responses in long-term HIV infected donors. Clin Exp Immunol. 2002

Dec;130(3):509-17.

" Collectively, these observations indicated that qualitative factors

within the CD8+ T cell response, not measured by current assays, may

be the principal determinants of control over HIV replication and

disease progression…The differential capacity of CD8+ T cells of

LTNPs [Long-Term Non-Progressors] to proliferate when stimulated with

HIV-infected CD4+ T cells is a measure of antiviral effector function

that has permitted us to distinguish the HIV-specific CD8+ T cell

response of these patients from those with progressive HIV infection.

Differences in suppressive activity, beta-chemokine secretion, direct

cytotoxicity, frequency, peptide specificities or expression of IFN-

gamma, tumor necrosis factor alpha or IL-2 by HIV-specific CD8+ T

cells did not account for differences in restriction of HIV

replication…So far we have been unable to detect diminished

production of IL-2 or other cytokines in the HIV-specific cells of

progressors that would be typical of functional defects described in

animal models consistent with anergy, clonal exhaustion or deficient

T cell help. [in other words, there are no tests that can distinguish

the immune system of those who will progress to AIDS, and those who

will not. And, as usual, other disease factors than HIV are not

considered] "

es SA et al. HIV-specific CD8+ T cell proliferation is coupled

to perforin expression and is maintained in nonprogressors. Nature

Immunology. 2002 Nov;3(11):1061-8.

" According to one paradigm [the one that made Dr. Ho briefly

famous], the demand for CD4 T cell production in response to rapid

virus-mediated destruction is the direct cause of increased turnover.

Progressive depletion of CD4 T cells is accordingly seen as a failure

of production to keep up with the rate of loss. This hypothesis has

been challenged on several grounds…The quantitatively similar

association between CD4 depletion and immune activation in HIV-1 and

HIV-2 infections we report in this work supports the hypothesis that

immune activation drives depletion…It is very unlikely that the

similar rates of CD4 T cell turnover, found in HIV-1 and HIV-2

patients with comparable levels of CD4 depletion, are associated with

similar turnover rates of infected cells despite the large difference

in viremia levels. "

Sousa AE et al. CD4 T Cell Depletion Is Linked Directly to Immune

Activation in the Pathogenesis of HIV-1 and HIV-2 but Only Indirectly

to the Viral Load. J Immunol. 2002 Sep 15;169:3400-6.

" Researchers need to establish what constitutes 'normal' blood levels

of CD4 cells in different populations in developing countries. "

son J. Cheaper HIV drugs for poor nations bring a new

challenge: monitoring treatment. JAMA. 2002 Jul 10;288(2):151-3.

" Some serious illnesses, especially active tuberculosis and

bacteremic pneumonia, may occur when the CD4 cell count is above

200/microliter…The available data from cohort studies, with one

exception, have not been able to define a CD4 stratum above 200

cells/microliter at which patients benefit from initiation of therapy…

In persons with CD4 cell counts above 350/microliter, risk of 3-year

clinical progression [to AIDS] is low and additional concerns about

impact of antiretroviral regimens on quality of life, risk of serious

adverse drug effects, and limitations on future treatment options

generally outweigh the benefits of durable viral suppression. "

Yeni PG et al. Antiretroviral treatment for adult HIV infection in

2002: updated recommendations of the International AIDS Society-USA

Panel. JAMA. 2002 Jul 10;288(2):222-35.

" The controversy currently revolves around one key question: at what

CD4+ cell count can the greatest benefit of therapy be achieved with

the lowest possible risk of disease progression, drug toxicity, and

drug resistance?…[a little later]…if the goal of therapy is to halt

further immune deterioration, starting treatment when the CD4+ cell

count is between 200 and 350 cells/mm3 may be sufficient. However, if

the goal is more complete CD4+ cell restoration, early initiation of

therapy may be more effective. [where was all that talk about drug

toxicity and disease progression? That seems to have vanished from

consideration.] "

KY. When should antiretroviral therapy be initiated?. Medscape

HIV/AIDS. 2002;8(1)

http://hiv.medscape.com/Medscape/HIV/journal/2002/v08.n01/mha0117.01.s

mit/mig-pnt-mha0117.01.smit.html.

" The median percentage of CD8+ T lymphocytes increased from 38% at

entry to 44% at follow-up in the 21 HIV-infected children with

measles studied at both time points (P = .02). In contrast to the

median number of CD4+ T lymphocytes, the median number of CD8+ T

lymphocytes increased 2-fold from 1169 cells/mm3 at entry to 2477

cells/mm3 at follow-up in these 21 coinfected children (P = .002).

The median percentage and number of CD8+ T lymphocytes in coinfected

children were approximately double those in HIV-uninfected children

with measles and HIV-uninfected control children. "

Moss WJ et al. Suppression of Human Immunodeficiency Virus

Replication during Acute Measles. J Infect Dis. 2002 Mar 25;184.

" Consistent with the analyses reported here, these data indicate that

direct virus-induced killing of infected CD4+ T cells alone cannot

account for the numerical and functional depletion of CD4+ T cells

leading to AIDS. Rather, AIDS progression reflects a complex balance

between the direct impact of the virus and the nature of the host

response to the infection [using SIV, Simian Immunodeficiency Virus

as a model for HIV] "

Regoes RR et al. Contribution of peaks of virus load to Simian

Immunodeficiency Virus pathogenesis. J Virol. 2002 Mar;76(5):2573-8.

" The median CD4 cell count increased over time for each treatment

group (91 at TB diagnosis and 300 at 12 months for no ARV [anti-

retroviral therapy]; 65 and 160 for dual ARV and 59 and 144 for HAART

[Highly Active Antiretroviral Therapy, including 3 or more drugs] ...

[Note that CD4 cell counts were about double in TB patients not

taking AIDS drugs!] "

Dean GL, SG, Ives NJ. Treatment of tuberculosis in HIV-

infected persons in the era of highly active antiretroviral therapy.

AIDS. 2002 Jan 4;16(1):75-83.

" We did not find that the level of immunosuppression [CD4 counts in

HIV+ African gold miners] increased the risk of overall recurrence,

relapse, or reinfection [with Tuberculosis, an AIDS-defining

condition in HIV+ people] "

Sonnenberg P et al. HIV-1 and recurrence, relapse, and reinfection of

tuberculosis after cure: a cohort study in South African mineworkers.

Lancet. 2001 Nov;358(17):1687-93.

" Two years before the virus that causes AIDS was discovered,

physicians in the United States and Europe realized that the defining

symptom of the mysterious new disease was the loss of a specific

immune system cell population, called CD4 cells. Twenty years later

scientists still don't know what kills the cells [but, gee, we all

thought it was HIV!]. And its eventual discovery will be key to

understanding AIDS - defined as a rise in the numbers of viruses in

the bloodstream coupled with a fall in the CD4 cell count.

[However]...it is not in HIV's interests to kill off its " home " [CD4]

cell, most scientists believe a complex interaction is at play,

causing the cells' deaths [translation: HIV doesn't kill CD4 cells

and therefore cannot be the cause of AIDS] "

Garrett L. Immune cell deaths still a stubborn puzzle. Newsday. 2001

Jun 5;C08.

" Declining host selenium levels...inhibit CD4 T cell production,

which permits opportunistic infectious pathogens to proliferate.

These pathogens in turn lead to further depression of serum selenium

levels and associated decline in CD4 T cell count "

HD. AIDS and the Selenium-CD4 T Cell Tailspin, the geography

of a pandemic. Townsend Letter. 2000 Dec;94-9.

" HIV-1 infects CD4+ T cells but direct infection and killing of these

cells can only partly account for HIV-1-associated lymphocyte

depletion. The actual number of productively infected cells is

estimated to be relatively low, in the order of 5 X 10^7 to 5 X 10^8

CD4+ T cells whereas the human body contains an average of 2.5 X

10^11 CD4+ T cells. Direct infection of CD4+ T cells does not explain

the loss of naive CD8+ T cells that parallels the decline in naive

CD4+ T cells during asymptomatic HIV-1 infection.

More important in this respect may be the response of the immune

system. HIV-1 activates the immune system persistently because of

high and continuous virion production and possibly by viral gene

products such as Nef. "

Hazenberg MD et al. T cell depletion in HIV-1 infection: how CD4+

cells go out of stock. Nature Immunology. 2000 Oct;1:285-9.

" Previously published data on CD4 cell count changes during therapy

interruptions have mainly consisted of reports on very small numbers,

but there has been a tendency to observe a distinct fall in numbers.

The relatively rapid early fall in CD4 cell count after interrupting

therapy may correspond to the relatively rapid increase in CD4 cell

count after initiating therapy, which has been ascribed to the

redistribution of cells from the lymphoid tissue [i.e. CD4 cells may

not be increased with antiretroviral therapy, merely shuffled around

the body to places where they are easier to measure] "

Youle M et al. Changes in CD4 lymphocyte counts after interruption of

therapy in patients with viral failure on protease inhibitor-

containing regimens. AIDS. 2000 Aug 18;14(12):1717-1720.

" Several of the features of Leishmania infection are reminiscent of

HIV infection. In both, there is a decrease of CD4 lymphocytes, the

immune activation profile is similar, and a dominant TH2 profile is

present...All helminthic infections are associated with strong

chronic immune responses...[including] decreased CD4 and CD4:CD8

ratios "

Bentwich et al. EDITORIAL REVIEW: Concurrent infections and HIV

pathogenesis. AIDS. 2000;14:2071-81.

" Controversy continues regarding the effects of HAART on CD4 T-cell

production...our understanding the mechanisms that lead to depletion

of CD4 T cells remains incomplete. The observation that T-cell

turnover in SIV-infected mangabeys appears to be normal, despite high

viral loads, has reinforced the hypothesis that indirect mechanisms

may be largely responsible for increases in T-cell turnover, yet

there is little solid evidence on how HIV and SIV mediate this effect

[translation: we don't have a clue how HIV kills CD4 cells] "

RP. The dynamics of T-Lymphyocte turnover in AIDS. AIDS.

2000;14(suppl 3):S3-9.

" The data should also serve as a strong reminder that using the CD4+

cell count as a surrogate for HIV testing has a risk of markedly

overestimating the diagnosis of HIV. Therefore, CD4+ cell counts

should not be relied on for a presumptive diagnosis of HIV in lieu of

consent for serologic testing. Finally, a larger study of CD4+ cell

counts in critically ill individuals might better define the

prognostic value of a low result. "

Aldrich J et al. The Effect of Acute Severe Illness on CD4+

Lymphocyte Counts in Nonimmunocompromised Patients . Arch Intern

Med. 2000 Mar 13;160(5):715-6.

" Tenfold (1 log10) incremental increases in maternal HIV RNA were

associated with a 1.9-fold increase (95% confidence interval [CI],

1.2-2.9) in transmission and a 2.1-fold increase (95% CI, 1.3-3.5) in

infant mortality (P<.01). Maternal CD4 cell counts and demographic

and medical characteristics were not significant predictors of

transmission. However, maternal CD4 cell counts below the median

(400/mm3) were significantly associated with infant mortality

(P=.035, Fisher's exact test) [i.e. CD4 cell counts might predict ill-

health, but don't seem to be particularly associated with HIV/AIDS] "

Katzenstein DA et al. Serum Level of Maternal Human Immunodeficiency

Virus (HIV) RNA, Infant Mortality, and Vertical Transmission of HIV

in Zimbabwe. J Infect Dis. 1999 Jun;179(6):1382-7.

" breast-fed [healthy, HIV-negative] infants had fewer CD4 T cells and

a great number of NK [natural killer] cells than the age-matched

formula-fed infants...suggesting greater maturity in the development

of the immune system of breast-fed infants "

Hawkes JS et al. The effect of breast feeding on lymphocyte

subpopulations in healthy term infants at 6 months of age. Pediatr

Res. 1999 May;45(5):648-51.

" This analysis confirms that the rate of removal of CD4+ T cells is

indeed elevated and the half-life is indeed shortened in the HAART

group [i.e. therapy might raise the level of CD4+ cell counts, but

they are not the same as normal immune cells, and might not be doing

any good] "

Hellerstein M et al. Directly measured kinetics of circulating T

lymphocytes in normal and HIV-1 infected humans. Nat Med. 1999 Jan;5

(1):83-9.

" Margolick...and, independently, Adleman and Wofsy proposed the BH

[blind Homeostasis] hypothesis. They postulated that, normally, a

constant number of T lymphocytes is maintained regardless of the CD4

to CD8 ratio...[and] would necessarily lead to a progressive

depletion of the CD4 compartment in HIV infection if CD4 cells are

preferentially destroyed by the virus...[based on the detailed

analysis in this paper] we consider the original BH hypothesis and

also its more elaborate version to be biologically rather

implausible...If correct, the BH hypotheses, but not the alternative

hypothesis, could account for CD4 cell depletion by HIV. However, as

we have discussed, there is no compelling evidence in favor of BH,

either inherent or HIV imposed...these considerations also suggest a

need to reevaluate current concepts about HIV pathogenesis, including

the concept that a systemic depletion of CD4 T cells is the hallmark

of the disease. "

Grossman Z et al. Conservation of total T-cell counts during HIV

infection: alternative hypotheses and implications. J Acquir Immune

Defic Syndr. 1998;17(5):450-7.

" new data point towards a different cause of CD4+ T-cell depletion in

HIV-1 infection [other than direct cell killing]. Exhaustion of

renewal driven by huge turnover of CD4+ T cells seems no longer a

plausible cause for CD4+ T-cell depletion. Alternatively, CD4+ T-cell

depletion might be caused either by interference with renewal due to

virus-related damage, or by an intrinsically limited renewal rate of

the immune system [the word 'might' indicates that they really don't

know, and immune system depletion might be due to other factors than

HIV] "

Wolthers KC et al. Rapid CD4+ T-cell turnover in HIV-1 infection: a

paradigm revisited. Immunology Today. 1998 Jan;19(1):44-8

..

" Clearly the change in CD4/CD8 ratio [often declared to be the

hallmark of AIDS] and immune function is multifactorial and cannot be

explained solely by a model of CD4+ cell destruction by virus…Indeed,

in terms of number and function, CD8+ subsets are more altered by HIV

infection than CD4+ cells [even though CD4 cell counts are commonly

used as a measure of immune suppression caused by HIV] "

Rosenberg YJ, AO, Pabst R. HIV-induced decline in blood

CD4/CD8 ratios: viral killing or altered lymphocyte trafficking?.

Immunology Today. 1998 Jan;19(1):10-7

..

" We present two cases of severe PCP [pneumocystis carinii pneumonia]

in infants who were perinatally exposed to HIV [and AZT] but who were

uninfected with HIV…Both children had a transient decrease in their

CD4 cell counts that was concomitant with the acute PCP episode "

Heresi GP et al. Pneumocystis carinii pneumonia in infants who were

exposed to human immunodeficiency virus but were not infected: an

exception to the AIDS surveillance case definition. Clin Infect Dis.

1997 Sep;25(3):739-40.

" During HIV infection, CD4+-cell numbers and CD4/CD8 ratios decline

in the blood. This is usually attributed to direct viral killing or

to other indirect mechanisms. However, current models generally

assume that such changes in the blood are representative of changes

in total CD4+-cell numbers throughout the body. This article

discusses the importance of alterations in CD4+- and CD8+-cell

migration in regulating blood lymphocyte levels and questions the

extent of virus-mediated CD4+-cell destruction "

Padian NS et al. Heterosexual Transmission of Human Immunodeficiency

Virus (HIV) in Northern California: Results from a Ten-Year Study. Am

J Epidemiol. 1997 Aug;146(4):350-7.

" The summary of results from a 1993 state-of-the-art conference shows

that the effect of treatment on the most popular surrogate, the CD4

cell count, did not accurately predict the effect of treatment on the

clinical outcomes, that is, progression to AIDS or time to death "

Fleming TR, DeMets DL. Surrogate End Points in Clinical Trials: Are

We Being Misled?. Ann Intern Med. 1996 Oct 1;125(7):605-13.

" The CDC definition of idiopathic CD4 lymphocytopenia [HIV-free AIDS]

does not include any clinical parameters. [One group] comprises a

series of individuals...who have CD4 counts which are low but in whom

there is no clinical evidence suggestive of immunodeficiency...[some

of these are] individuals whose CD4 counts are below the lower end of

the normal range and who have constitutionally low CD4 blood levels

consistently over a period of time without ill effect...their low CD4

counts may have no prognostic significance "

Bird AG. Non-HIV AIDS: nature and strategies for its management.

Journal of Antimicrobial Chemotherapy. 1996;37(B):171-183.

" Despite its value as a general marker of disease stage, the CD4

count alone is inadequate as a means of measuring prognosis [i.e.

declining counts do not necessarily predict AIDS, and vice-versa] "

Saag MS et al. HIV viral load markers in clinical practice. Nat Med.

1996 Jun;2(6):625-9.

" In clinical practice, a CD4+ T cell count of <500 cells/microliter

is commonly used as a trigger to initiate antiretroviral therapy.

This practice requires reevaluation in light of our observations that

subjects with CD4+ T cell counts of >=500 cells/microliter can

progress as rapidly to AIDS and death as those with much lower

counts "

Mellors JW et al. Prognosis in HIV infection predicted by the

quantity of virus in plasma. Science. 1996 May 24;272(5265):1167-70.

" [a study of the CD4 cell counts of 102 intensive care unit

admissions] Our results demonstrate that acute illness alone, in the

absence of HIV infection, can be associated with profoundly depressed

lymphocyte concentrations [e.g. CD4 cells]. Although we hypothesized

that this depression would be directly related to the severity of

illness, this relationship was not seen in our results. The T-cell

depression we observed was unpredictable and did not correlate with

severity of illness, predicted mortality rate or survival rate "

Feeney C et al. T-lymphocyte subsets in acute illness. Crit Care Med.

1995 Oct;23(10):1680-5.

" The understanding of the pathogenesis of AIDS has probably suffered

seriously from two major shortcomings. First, HIV has been

wrongly...assumed to be cytopathic in vivo and second, for obvious

practical reasons, only peripheral blood has been analyzed and

therefore CD4+ T-cell counts in blood have captured too much

attention. As stated above, there is good evidence that many host

cells other than CD4+ T cells are infected by HIV, and there is no

convincing evidence that HIV is cytopathic in vivo "

Zinkernagel R. Are HIV-specific CTL responses salutary or

pathogenic?. Curr Opin Immunol. 1995;7:462-70.

" In a small percentage of persons infected with human

immunodeficiency virus type 1 (HIV-1), there is no progression of

disease and CD4+ T-cell counts remain stable for many years...We

studied 15 subjects with long-term nonprogressive HIV infection and

18 subjects with progressive HIV disease. Nonprogressive infection

was defined as seven or more years of documented HIV infection, with

more than 600 CD4+ T cells per cubic millimeter, no antiretroviral

therapy, and no HIV-related disease. "

Pantaleo G et al. Studies in subjects with long-term nonprogressive

Human Immunodeficiency Virus Infection. N Engl J Med. 1995 Jan 26;332

(4):209-16.

" There was no consistent pattern in CD4 cell counts with progression

of disease [in young European HIV+ children]. Evidence of

immunologicc impairment as measured by CD4 count was more common than

clinical manifestations of HIV infection. An estimated 17% of

infected children who had not yet developed AIDS had ever had a CD4

count below the third percentile by 6 months of age, about 34% by age

1 year, and 54% by age 3 years…there was no clear association between

CD4 cell count and onset of disease or death, or between CD4 levels

before and after AIDS [note: a rare admission that `AIDS' can go as

well as come] "

European Collaborative Study. Natural history of vertically acquired

human immunodeficiency virus. Pediatrics. 1994 Dec;94(6):815-9.

" CD4 [immune cell] count fell less rapidly with high-purity [Factor

VIII clotting] products. "

Goedert JJ et al. Risks of immunodeficiency, AIDS, and death related

to purity of factor VIII concentrate. Lancet. 1994 Sep 17;344

(8925):791-2.

" The median CD4 lymphocyte count did not differ in the 3 groups: 54

for the group receiving neither antiretroviral nor P. carinii

pneumonia prophylaxis, 53 for the group receiving only antiretroviral

therapy, and 52 for the combined treatment group. There were also no

major differences in the median CD8 lymphocyte count of the 3 groups

[indicates that CD4 cell counts are not always improved by

treatment] "

Bacellar H et al. Incidence of clinical AIDS conditions in a cohort

of homosexual men with CD4+ cell counts < 100/cubic mm. J Infect Dis.

1994;170:1284-7.

" In this report, we present data on the prevalence of CD4+ T-

lymphocytopenia [low CD4 cell counts in HIV-negative people] among

healthy, volunteer, anti-HIV-1-negative blood donors...Five (0.25%)

of 2030 index donations had a CD4+ count <300 cells per micrometer or

a CD4+ percentage <20% "

Busch MP et al. Screening of blood donors for idiopathic CD4+ T-

lymphocytopenia. Transfusion. 1994;34(3):192.

" 52 centres in 17 [European] countries participated in the study.

Centres provided data on all patients diagnosed with AIDS between

1979 and 31 December 1989…For patients with konwn CD4 cell counts

there was a significant association between CD4 cell count and

survival "

Lundgren JD et al. Survival differences in European patients with

AIDS, 1979-89. The AIDS in Europe Study Group. BMJ. 1994 Apr 23;308

(6936):1068-73.

" We found that among those with CD4 lymphocyte counts less than [200

per cubic millimeter], survival was highly dependent on clinical

status [i.e. current health]. Those who were asymptomatic or were

symptomatic but with no AIDS-defining clinical conditions had

considerably better survival outcomes than those who had clinical

AIDS, suggesting that while CD4 lymphocyte count is a reasonable

predictor of duration of survival among homogenous clinical groups,

the presence of a clinical AIDS-defining condition plays a major role

[i.e. CD4 cell counts, by themselves, are not good predictors of

survival in HIV-positive people] "

Vella S et al. Differential Survival of Patients With AIDS According

to the 1987 and 1993 CDC Case Definitions. JAMA. 1994 Apr 20;271

(15):1197-9.

" The results of Concorde [a clinical trial of AZT] do not encourage

the early use of zidovudine in symptom-free HIV-infected adults. They

also call into question the uncritical use of CD4 cell counts as a

surrogate endpoint for assessment of benefit from long-term

antiretroviral therapy "

Concorde Coordinating Committee. Concorde: MRC/ANRS randomised double-

blind controlled trial of immediate and deferred zidovudine in

symptom-free HIV infection. Lancet. 1994 Apr 9;343(8902):871-81.

" Some HIV-infected individuals have remained healthy for more than 15

years following seroconversion. Lower numbers of CD4+ peripheral

blood lymphocytes have generally been found to indicate the

advancement of HIV disease... [but] The CD4+ cell counts vary from

day to day and laboratory to laboratory, and similar levels do not

necessarily reflect the same disease status in all patients. For

example, very low CD4+ cell counts (less than 0.05x10^9/L) usually

indicate advanced disease; however, some patients with these levels

remain asymptomatic for extended periods of time while others succumb

rapidly "

National Institute of Allergy and Infectious Diseases State-of-the-

Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients

et al. Anti-retroviral therapy for adult HIV-infected patients.

Recommendations from a state-of-the-art conference. JAMA. 1993 Dec

1;270(21):2583-9.

" More than 15% of the HIV-1-seropositive [iV-drug-using] individuals

had plasma vitamin A levels less than 1.05 micromol/L, a level

consistent with vitamin A deficiency. The HIV-1-seropositive

individuals had lower mean plasma vitamin A levels than HIV-1-

seronegative individuals (p<.001). Vitamin A deficiency was

associated with lower CD4 levels among both seronegative individuals

(p<.05) and seropositive individuals (p<.05). In the HIV-seropositive

participants, vitamin A deficiency was associated with increase

[indicates that CD4 cell counts can be modified by things other than

HIV] "

Semba RD et al. Increased Mortality Associated with Vitamin A

Deficiency During HIV 1 Infection. Arch Intern Med. 1993 Sep

27;153:2149-54.

" We designed a multicentre, prospective, randomised, controlled study

of symptom-free HIV-infected patients with haemophilia A who were

assigned to receive either an intermediate-purity [Factor VIII blood

clotting factor] or monoclonal-antibody-purified [`high purity']

product…35 completed the 3 year study, 20 in the monoclonal arm and

15 in the intermediate-purity arm [many in this arm leaving to start

on high purity Factor VIII]. Among those completing the study, there

were no differences between the two groups in the occurrence of AIDS-

defining diagnoses (1 in each group). There were, however, striking

and significant differences in terms of changes in absolute CD4

counts. The group receiving monoclonal-antibody-purified concentrates

had essentially stable counts while a significant drop was observed

in the group receiving intermediate-purity F[actor] VIII. These

differences were independent of the use of antiretroviral therapy. "

Seremetis SV et al. Three-year randomised study of high-purity or

intermediate-purity factor VIII concentrates in symptom-free HIV-

seropositive haemophiliacs: effects on immune status. Lancet. 1993

Sep 18;342(8873):700-3.

" CD4 cell counts and percentages were obtained from 1,246 HIV-

seronegative subjects...Nine had at least one CD4 cell count of <300

cells/micrometer or a CD4[:CD8 ratio] <20%...Four subjects had CD4

counts <300 cells/micrometer or CD4 < 20% for two points in time,

meeting the current surveillance definition for ICL [HIV-free

AIDS]...We also examined the data for the 21 subjects who had one CD4

count between 300 and 500 cells/micrometer and for whom there was at

least one follow-up data collection. None of these subjects

progressed to a CD4 cell count of <300 cells/micrometer or a CD4<20%

at any follow-up visit. Five of these 21 subjects later seroconverted

for HIV [indicating that low CD4 cell counts preceded infection, and

could not have been caused by HIV] "

Des Jarlais DC et al. CD4 lymphocytopenia among injecting drug users

in New York City. J Acquir Immune Defic Syndr. 1993;6:820-2.

" 36 subjects treated with high-purity [Factor VIII blood clotting]

concentrate for 6 months or more had a smaller decline in CD4 than 72

matched controls on intermediate-purity concentrate. In a more

complex analysis with 226 subjects, CD4 counts declined 3% less per 6

months with high-purity material than with intermediate product (p =

0.04). "

Hilgartner MW et al. Purity of factor VIII concentrates and serial

CD4 counts. The Transfusion Safety Study Group. Lancet. 1993 May

29;341(8857):1373-4.

" 47 cases of AIDS were identified among the seropositive [iV drug

using] subjects during the study period. The likelihood of developing

AIDS was inversely related to the CD4 cell count at baseline...

[but]...The principal finding was the slow rate of decline in CD4

lymphocyte counts in HIV-1 seropositive IVDUs over a 2.5 year period

[and some cases of AIDS occurred at quite high CD4 cell counts] "

Margolick JB et al. Changes in T-Lymphocyte subsets in intravenous

drug users with HIV-1 infection. JAMA. 1992;267:1631.

" CD4+ [immune cell] counts were higher in cases with KS [a skin

cancer], lymphoma, HIV encephalopathy and wasting, compared with

cases with Opportunistic Infections [but this does not match the

theory that HIV attacks CD4 cells and causes immune suppression] "

Schwartlander B et al. Changes in the spectrum of AIDS-defining

conditions and decrease in CD4+ lymphocyte counts at AIDS

manifestation in Germany from 1986 to 1991. AIDS. 1992 Apr;6(4):413-

20.

" In the group [of 10 asymptomatic HIV-positive hemophiliacs] switched

to the very high purity [Factor VIII] concentrate there was no

significant change of the CD4 cell counts over the 96-week follow-up

period, whereas in the group continued on the intermediate purity

concentrate [also 10 asymptomatic HIV-positive hemophiliacs], a

highly significant decline was detected (p < .013) [indicates that

CD4 cell counts are affected by the purity of blood products] "

de Biasi R et al. The impact of a very high purity of factor VIII

concentrate on the immune system of Human Immunodeficiency Virus-

infected hemophiliacs: a randomized, prospective, two-year comparison

with an intermediate purity concentrate. Blood. 1991 Oct 15;78

(8):1919-22.

" CD4 counts have been closely followed in [hemophiliac] patients

treated with different [blood clotting] factor concentrates.

Stabilization of counts and reversal of skin-test anergy have been

reported following 24 months of therapy with Monoclate [a high purity

blood clotting factor, with fewer immunosuppressive foreign

proteins] "

Schulman S. Effects of factor VIII concentrates on the immune system

in hemophilic patients. Ann Hematol. 1991 Sep;63(3):145-51.

" some healthy seropositive individuals lose a large proportion of

their CD4+ lymphocytes, yet do not develop symptoms...Two patients

followed at our medical center have had only 5% of their normal CD4+

cell number for over a year without any new symptoms. Thus,

predictions on the development of opportunistic infections or cancers

based solely on a decrease in CD4+ cells could be misleading. "

Levy JA. Mysteries of HIV: challenges for therapy and prevention.

Nature. 1988 Jun 9;333:519-22.

" tuberculosis itself depresses T-cell function and causes a reversed

helper [CD4] : suppressor [CD8] T-cell ratio "

Pitchenik AE et al. Human T-cell lymphotropic virus-III (HTLV-III)

seropositivity and related disease among 71 consecutive patients in

whom tuberculosis was diagnosed. A prospective study. Am Rev Respir

Dis. 1987 Apr;135(4):875-9.

" [A] real T-helper [CD4] lymphopenia is only consistent with and not

diagnostic of AIDS [even though it is now used to diagnose AIDS];

other diseases and some treatment regimens also can express a T-

helper lymphopenia [deficiency], such as hospitalized non-AIDS IV

drug abusers "

Layon J, Warzynski M, Idris A. Acquired immunodeficiency syndrome in

the United States: a selective review. Crit Care Med. 1986;14(9):819-

27.

" The 53 patients studied included 15 homo- and 11 heterosexual men

with chronic HBV [Hepatitis-B Virus] infection, as well as 11 homo-

and 16 heterosexual men who were in apparent good health...Only 4

patients in this study had detectable anti-HIV [HIV antibodies] by

ELISA...The mean [CD4/CD8] ratio was significantly lower in

homosexual men, independent of HBV infection...Although 4 patients in

this study had [HIV antibodies], the association of the abnormalities

of T lymphocyte subsets [CD4/CD8] and NK [Natural Killer] activity

with homosexuality remained significant after exclusion of these 4

patients from the data analysis [this paper does not consider the

possibility that nitrite inhalants, almost exclusively marketed and

used by homosexual men, could have affected the CD4/CD8 cell counts] "

Novick DM et al. Influence of Sexual Preference and Chronic Hepatitis

B Virus Infection on T Lymphocyte Subsets, Natural Killer Activity,

and Suppressor Cell activity. J Hepatol. 1986;3:363-370.

" Between April and October, 1984, anti-HTLV-III [HIV antibodies]

developed in 16 patients with hemophilia A...[of whom] all but one

had received a common batch [of clotting] factor VIII...a further

eighteen patients received the implicated batch A...[but] have been

negative for [HIV antibodies]...Lymphocyte subsets [CD4/CD8 cells]

were investigated in 24 of the patients...the patients in whom [HIV

antibodies] later developed had lower [CD4/CD8] ratios than those who

did not seroconvert and the controls. The difference...just failed to

reach statistical significance. In 1983 the absolute [CD4] cell

numbers in those who subsequently seroconverted were significantly

lower than those in the controls...The 15 patients who seroconverted

used significantly more vials of batch A and also had a higher annual

factor VIII consumption than the eighteen patients who did not

seroconvert...Our finding in this study that T-helper-cell numbers

and the helper/suppressor ratio did not change after infection

supports our previous conclusion that the abnormal T-lymphocyte

subsets [CD4/CD8 cells] are a result of the intravenous infusion of

factor VII concentrates per se, not [HIV] infection "

Ludlam CA et al. Human T-Lymphotropic Virus Type-III (HTLV-III)

Infection in Seronegative Hemophiliacs after Transfusion of Factor

VIII. Lancet. 1985 Aug 3;2(8449):233-236.

" The commonest cause of T-cell [CD4 cell] immunodeficiency worldwide

is protein-calorie malnutrition…[in Developing Countries] the

widespread distribution of parasitic infections with known

immunosuppressive activity leading to opportunistic infections, and

the coexistence of mulitple parasites in the same subject [person],

make it difficult to identify patients with AIDS on the basis of the

current epidemiologic criteria [e.g. the `Bangui' definition] and

immunologic aberrations [i.e. low CD4 cell counts or abnormal CD4/CD8

ratios] "

Seligmann et al. AIDS - an immunologic reevaluation. N Engl J Med.

1984 Nov 15;311(20):1286-92.

" we tested six asymptomatic asthmatics who were sensitive to mixed

grass (positive skin test) with mixed grass extract, methacholine,

and an antigen to which they were not sensitized (negative skin

test). Levels of OKT4 [CD4] (helper T lymphocytes) were reduced in

the peripheral blood immediately after the challenge with mixed grass

extract, and remained low for at least 72 hours [note that low CD4

cell counts are supposed to be unique to AIDS by many accounts] "

Adi A et al. Change in T-cell Lymphocyte Subpopulations after

Antigenic Bronchial Provocation in Asthmatics. N Engl J Med. 1984

May;310(21):1349-52.

" follow-up studies after booster immunization with tetanus toxoid

revealed a significant decrease in the OKT4[CD4+]/OKT8[CD8+] ratios.

In 4 of the 11 healthy volunteers, the OKT4/OKT8 ratio fell to 1 or

less…The decrease in the OKT4/OKT8 ratio after vaccination was due to

a reduction of OKT4+ cells in the peripheral blood of these donors…

The results presented in this letter demonstrate that abnormal T-

lymphocyte helper/suppressor ratios can be detected in healthy

persons after immunization with a widely used antigen. "

Eibl M et al. Abnormal T-lymphocyte subpopulations in healthy

subjects after tetanus booster immunization. N Engl J Med. 1984 Jan

19;310(3):198-9.

" Ten patients (6 males and 4 females)...were studied during the

acute...or convalescent phases of CMV[Cytomegalovirus]-

mononucleosis..Analysis of the T lymphocyte subsets..indicated both

relative and absolute reductions in the T helper [CD4] subset and

simultaneous increases in the T suppressor [CD8] population...Recent

studies suggest that a delicate balance exists between helper [CD4]

and suppressor [CD8] T lymphocytes in the maintenance of immune

homeostasis. Several disease states have been associated with

alterations in this balance [not just HIV, even though an imbalance

in CD4/CD8 cell counts is now considered, along with an HIV test,

diagnostic for AIDS, at least in the USA] "

Carney WP et al. Analysis of T lymphocyte subsets in Cytomegalovirus

mononucleosis. The Journal of Immunology. 1981;126(6):2114-6.

>

> On Tue, 31 May 2005 21:26:03 -0600 " Caermail " <caerfree@w...>

> writes:

>

> > If it were me, I would never take the medications. I would

rather

> > die honestly. Besides, what it does to your T-Cells is merely a

> > mask. You will feel better, all the while, killing your own bone

> > marrow to the point that you are not able to produce any more.

>

>

> )======== And what might those particular meds be that do this(I've

only

> heard of AZT doing that)? OH,.....so low cd'4s or what ever count

you

> have has absolutely no correlative or indication of anything going

on in

> your body relative to immunity - is that the claim? Dissidents have

yet

> to prove that cd-4's are irrelevant and the general data points

> consisently to OI's being more 'opportunist' at lower cd-4 counts.

While

> these lower counts may or may not have anything to do with the

hiv...they

> still are usually a fairly good indicator on ones immune-response

status.

> (ave. cd-4's range from 500 - 1500) This is the general

concensus...and

> until it is disproven...it remains to be reckoned with.

>

> A good cleanse sounds good!

>

>

> paul

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...